SyrSpend SF Suspending Base, Cherry Flavored, packaged in a) 500mL bottles (NDC 51552-1123-5) and b) 4L bottles (NDC 51552-1123-9), Rx Only, Manufactured for Fagron, Inc., St. Paul, MN 55120.
Published May 18, 2022 · Recall initiated: March 4, 2022
Summary
FDA records drug Class I recall D-0856-2022, published May 18, 2022 and initiated March 4, 2022. Recalling firm: Fagron, Inc; Status: Completed; Reported quantity: a) 559 bottles and b) 243 bottles; Lot: Lot #: a) A67185, Exp. Date 08/31/2024; b) Lot #: A67186, Exp. Date 08/31/2024. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Microbial Contamination of Non-Sterile Product: Product is contaminated with Burkholderia gladioli.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Fagron, Inc
- Distributor
- Nationwide USA and Puerto Rico, Canada, Columbia, France
- Lot
- Lot #: a) A67185, Exp. Date 08/31/2024; b) Lot #: A67186, Exp. Date 08/31/2024
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDANYSTATIN 2 BU, Activity (as is): 6482 Units/mg, bulk powder container, Rx Only, For Prescription Compounding,December 27, 2023
- FDANYSTATIN 5BU, Activity (as is): 6482 Units/mg, bulk powder container, Rx Only, For Prescription Compounding,December 27, 2023
- FDANYSTATIN 500 MU, Activity (as is): 6482 Units/mg, bulk powder container, Rx Only, For PrescriptionDecember 27, 2023
- FDANYSTATIN 150 MU, Activity (as is): 6482 Units/mg, bulk powder container, Rx Only, For PrescriptionDecember 27, 2023
- FDAMVASI (bevacizumab-awwb), Injection, For Intravenous Infusion After Dilution, 100 mg/4 ml, Single dose vial,May 18, 2022
- FDAbuPROPion Hydrochloride Extended-Release Tablet, USP (SR), 150 mg packaged in a) 60-count bottleMay 18, 2022
Questions about this recall
Was SyrSpend SF Suspending Base, Cherry Flavored, packaged in a) 500mL bottles (NDC 51552-1123-5) and b) 4L bottles (NDC 51552-1123-9), Rx Only, Manufactured for Fagron, Inc., St. Paul, MN 55120. recalled?
Yes. FDA published recall D-0856-2022 on May 18, 2022. Reported hazard: Microbial Contamination of Non-Sterile Product: Product is contaminated with Burkholderia gladioli.
What should I do if I have this product?
Voluntary: Firm initiated · Letter